US 11174232
Substituted heterocyclyl derivatives as CDK inhibitors
granted A61KA61K31/415A61K31/4155
Quick answer
US patent 11174232 (Substituted heterocyclyl derivatives as CDK inhibitors) held by Aurigene Discovery Technologies Limited expires Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aurigene Discovery Technologies Limited
- Grant date
- Tue Nov 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/415, A61K31/4155, A61K31/416, A61K31/4439